MEGAN VONWERSSOWETZ: Open Payments
NPI 1700241783 · CHATTANOOGA, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,315 in 65 payments from 16 companies in 2025. Trend: 2023 $805 · 2024 $1,097 · 2025 $1,315
Food & beverage: $1,315
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 19 | $467 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 14 | $255 |
| Lilly USA, LLC | 6 | $98 |
| PFIZER INC. | 4 | $75 |
| AstraZeneca Pharmaceuticals LP | 4 | $69 |
| Xeris Pharmaceuticals, Inc. | 3 | $65 |
| GlaxoSmithKline, LLC. | 3 | $46 |
| ABBVIE INC. | 2 | $45 |
| Inspire Medical Systems, Inc. | 2 | $36 |
| Axsome Therapeutics, Inc. | 2 | $36 |
Products named: CAPLYTA, Ozempic, Rybelsus, MOUNJARO, GVOKE HYPOPEN, FARXIGA, ELIQUIS, INSPIRE.
Industry payments across TN — which companies pay providers there.
